SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-22-000008
Filing Date
2022-05-10
Accepted
2022-05-10 08:30:52
Documents
89
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20220331x10q.htm   iXBRL 10-Q 2004380
2 EX-10.1 anip-20220331ex10114ef8b.htm EX-10.1 511446
3 EX-10.2 anip-20220331ex1026cf953.htm EX-10.2 532669
4 EX-31.1 anip-20220331ex311b22695.htm EX-31.1 11358
5 EX-31.2 anip-20220331ex31204809f.htm EX-31.2 10778
6 EX-32.1 anip-20220331ex3210b156d.htm EX-32.1 8605
  Complete submission text file 0001023024-22-000008.txt   10466583

Data Files

Seq Description Document Type Size
7 EX-101.SCH anip-20220331.xsd EX-101.SCH 58497
8 EX-101.CAL anip-20220331_cal.xml EX-101.CAL 83626
9 EX-101.DEF anip-20220331_def.xml EX-101.DEF 302968
10 EX-101.LAB anip-20220331_lab.xml EX-101.LAB 457617
11 EX-101.PRE anip-20220331_pre.xml EX-101.PRE 478389
83 EXTRACTED XBRL INSTANCE DOCUMENT anip-20220331x10q_htm.xml XML 1770623
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 22907518
SIC: 2834 Pharmaceutical Preparations